Coherus BioSciences is a biotechnology company focused on developing and commercializing innovative oncology products. The company is dedicated to minimizing access and reimbursement barriers for patients and healthcare providers, ensuring that patients can effectively access their oncology therapies. With a commitment to collaboration and education, Coherus works closely with healthcare facilities and stakeholders to navigate the complexities of the reimbursement cycle, ultimately aiming to optimize patient access to their product portfolio.